Convergence of Engineering and Biology

The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of biologic technology platforms to advance therapies that span multiple diseases.

Our technologies are applicable to a wide variety of diseases, including cardiovascular and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis, and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few.

Videos

  • Overview of Stem Cell Engineering
  • Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field.

News

 
Biologists Being Basic featured the lab's COVID cardiac work.
 
Sarah Rockwood and Marty Krakora share what it is like to be a Research Associate at Gladstone.
 
Will Flanigan says thank you to the Gladstone Research Associates for their appreciation week.
 
Todd McDevitt and his team developed an artificial intelligence approach to get a more comprehensive view of how cells behave and collaborate to form complex organs.
 
Chosen based on demonstrated excellence and engagement in their field of research.
 
Todd McDevitt and Bruce Conklin comment on COVID-19 cardiac research